TherapeuticsMD, Inc. Other Current Assets
TherapeuticsMD, Inc. (TXMD) had Other Current Assets of $755.15 thousand as of 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2015-11-05
- 2015-09-30: Other Assets, Current $755.15K.
- 2014-09-30: Other Assets, Current $100.00K.
- 2014-06-30: Other Assets, Current $2.68M.
- 2014-03-31: Other Assets, Current $2.30M.
| Period end | Other Assets, Current |
|---|---|
| 2015-09-30 | $755.15K 10-Q · filed 2015-11-05 |
| 2014-09-30 | $100.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.68M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.30M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $2.48M 10-Q · filed 2014-08-07 |
| 2013-09-30 | $3.42M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $3.61M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $2.18M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $751.94K 10-K · filed 2014-03-05 |
| 2012-09-30 | $851.84K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $899.81K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $437.71K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $496.06K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |